Patents by Inventor Samuel J. Asirvatham

Samuel J. Asirvatham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969197
    Abstract: This document describes methods and devices for treating ventricular fibrillation. For example, this document describes methods of performing electroporation of a ventricle and electroporation catheters. The methods can include inserting a distal end portion of a catheter into a ventricle of a heart of a patient, inflating a balloon coupled to the distal end portion of the catheter, occluding a valve of the heart associated with the ventricle with the balloon, injecting a fluid into the ventricle via an aperture defined by the distal end portion of the catheter, and generating an electrical current via an electrode on the distal end portion of the catheter.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: April 30, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Christopher V. DeSimone, Samuel J. Asirvatham, Christopher J. McLeod
  • Publication number: 20240123257
    Abstract: Particle or hadron therapy is used on abnormal tissue using carbon atoms, protons, or helium atoms run through a linear accelerator and then directed at the target in the body. This can be used to treat, for example, atrial fibrillation, ventricular tachycardia, hypertension, seizures, gastrointestinal maladies, etc. Contouring and gating may be used to account for cardiac and respiratory motion, helping reduce collateral damage.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 18, 2024
    Inventors: Douglas L. Packer, Samuel J. Asirvatham, Suraj Kapa
  • Publication number: 20240058057
    Abstract: Devices and methods can be used to treat of heart conditions, hypertension, and other medical disorders. For example, devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation are described herein. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 22, 2024
    Inventors: Samuel J. Asirvatham, David R. Holmes, JR.
  • Patent number: 11903670
    Abstract: Devices and methods for the treatment of heart conditions, and other medical purposes, include cardiac pacing systems. For example, this document describes temporary transvenous endocardial pacemaker systems and devices for deploying such systems without the need for conventional imaging procedures.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: February 20, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Peter M. Pollak, Samuel J. Asirvatham, Charles J. Bruce, Paul A. Friedman
  • Patent number: 11896379
    Abstract: Systems, methods, and computer program product embodiments are disclosed for displaying cardiac signals based on a signal pattern. An embodiment operates by accessing an input cardiac signal. The embodiment matches a portion of the input cardiac signal to a known signal pattern. The embodiment then displays an indication of a degree of the match.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: February 13, 2024
    Assignees: BioSig Technologies, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Budimir S. Drakulic, Sina Fakhar, Thomas G. Foxall, Branislav Vlajinic, Samuel J. Asirvatham
  • Patent number: 11857808
    Abstract: Particle or hadron therapy is used on abnormal tissue using carbon atoms, protons, or helium atoms run through a linear accelerator and then directed at the target in the body. This can be used to treat, for example, atrial fibrillation, ventricular tachycardia, hypertension, seizures, gastrointestinal maladies, etc. Contouring and gating may be used to account for cardiac and respiratory motion, helping reduce collateral damage.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: January 2, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Douglas L. Packer, Samuel J. Asirvatham, Suraj Kapa
  • Publication number: 20230414362
    Abstract: This document describes methods and devices for securing epicardial devices. For example, this document describes methods and devices for securing epicardial devices by passing a sheath into a pericardial space of a patient through a first percutaneous access site, passing a guidewire through the sheath into the pericardial space of the patient, passing the guidewire through a transverse sinus of the patient, passing a snare device into the pericardial space through a second percutaneous access site, and capturing a free end portion of the guidewire using the snare device.
    Type: Application
    Filed: September 13, 2023
    Publication date: December 28, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Paul A. Friedman
  • Patent number: 11844565
    Abstract: This document provides devices and methods for the treatment of heart conditions, hypertension, and other medical disorders. For example, this document provides devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: December 19, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, David R. Holmes, Jr.
  • Patent number: 11813471
    Abstract: This document describes methods and materials for reducing incision sizes for improving the treatment of pathological conditions, including arrhythmias and trauma, using temperature modulation via implantable devices. For example, this document describes methods and devices for treating atrial and/or ventricular fibrillation by cooling the epicardium.
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: November 14, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Paul A. Friedman, Samuel J. Asirvatham
  • Patent number: 11786375
    Abstract: This document describes methods and devices for securing epicardial devices. For example, this document describes methods and devices for securing epicardial devices by passing a sheath into a pericardial space of a patient through a first percutaneous access site, passing a guidewire through the sheath into the pericardial space of the patient, passing the guidewire through a transverse sinus of the patient, passing a snare device into the pericardial space through a second percutaneous access site, and capturing a free end portion of the guidewire using the snare device.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: October 17, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Paul A. Friedman
  • Patent number: 11771905
    Abstract: This document describes methods and materials for mapping and modulating repolarization. For example, this document relates to methods and devices for mapping and modulating repolarization to target atrial and ventricular arrhythmias to deliver electrical stimulation pacing, ablation and/or electroporation.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: October 3, 2023
    Assignee: Mayo Foundation for Medical Education & Research
    Inventors: Christopher J. McLeod, Samuel J. Asirvatham
  • Patent number: 11737699
    Abstract: Systems, methods, and computer program product embodiments are disclosed for performing electrophysiology (EP) signal processing. An embodiment includes an electrocardiogram (ECG) circuit board configured to process an ECG signal. The embodiment further includes a plurality of intracardiac (IC) circuit boards, each configured to process a corresponding IC signal. The ECG circuit board and the plurality of IC circuit boards share substantially a same circuit configuration and components. The ECG circuit board further processes the ECG signal using substantially a same path as each IC circuit board uses to process its corresponding IC signal.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: August 29, 2023
    Assignees: BioSig Technologies, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Budimir S. Drakulic, Sina Fakhar, Thomas G. Foxall, Branislav Vlajinic, Samuel J. Asirvatham
  • Publication number: 20230263578
    Abstract: Cystic lesions can be treated by electroporation. For example, this document describes methods and devices for endoscopic ultrasound-guided ablation of cystic lesions using a needle for electroporation.
    Type: Application
    Filed: May 2, 2023
    Publication date: August 24, 2023
    Inventors: Samuel J. Asirvatham, Barham K. Abu Dayyeh
  • Patent number: 11701172
    Abstract: A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space. The device performs modulation or ablation of the autonomic nervous system at selected treatment areas within the pericardium.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: July 18, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Mark B. Knudson
  • Patent number: 11697024
    Abstract: Devices and methods can be used for artificial cardiac pacing and/or resynchronization. For example, this document provides improved electrodes for stimulating and sensing electrical activity of the heart, and provides pacing and resynchronization systems incorporating such electrodes. While the devices and methods provided herein are described primarily in the context of pacing, it should be understood that resynchronization can additionally or alternatively be performed in an analogous manner, and that the scope of this disclosure includes such subject matter.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: July 11, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Paul A. Friedman, Charles J. Bruce, Samuel J. Asirvatham
  • Publication number: 20230181208
    Abstract: This document relates to devices and methods for the treatment of heart conditions. For example, this document provides devices and methods for treating heart failure with preserved ejection fraction, including diastolic heart failure, by performing a pericardial modification procedure.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 15, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Barry A. Borlaug, Vojtech Melenovsky
  • Patent number: 11672608
    Abstract: Cystic lesions can be treated by electroporation. For example, this document describes methods and devices for endoscopic ultrasound-guided ablation of cystic lesions using a needle for electroporation.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: June 13, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Barham K. Abu Dayyeh
  • Publication number: 20230165617
    Abstract: Systems and methods can be used to retrieve and remove blood clots from blood vessels. For example, this document describes catheter-based cryogenic devices that are used to retrieve and remove blood clots. The systems and methods provided herein can be used to remove blood clots from all types of blood vessels including, but not limited to, peripheral vessels, coronary arteries, central veins, pulmonary arteries, cerebral arteries, and any other type of blood vessel that can contain blood clots.
    Type: Application
    Filed: April 5, 2021
    Publication date: June 1, 2023
    Inventors: Samuel J. Asirvatham, Mohamad A. Alkhouli
  • Publication number: 20230149718
    Abstract: This document describes methods and materials for improving the delivery of electroporation. For example, this document describes methods and devices for delivering electroporation while mitigating risks of ventricular fibrillation.
    Type: Application
    Filed: December 30, 2022
    Publication date: May 18, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventor: Samuel J. Asirvatham
  • Publication number: 20230142793
    Abstract: This disclosure describes methods systems, and devices for treating atrial and ventricular fibrillation. For example, this document describes a method of terminating cardiac arrhythmias that includes generating a bipolar pulsed electrical field between a first electrode positioned on a first portion of a heart of a patient and a second electrode positioned on a second portion of the heart of the patient to cause reversible electroporation of myocardial cells of the heart.
    Type: Application
    Filed: March 30, 2021
    Publication date: May 11, 2023
    Inventors: Samuel J. Asirvatham, Paul A. Friedman